Stock Price
11.14
Daily Change
-0.14 -1.24%
Monthly
-7.71%
Yearly
-23.44%
Q3 Forecast
11.22

Clinuvel Pharmaceuticals reported AUD16.21M in Selling and Administration Expenses for its fiscal semester ending in June of 2024.


Selling And Administration Expenses Change Date
Avita Medical AUD 21.23M 2.57M Dec/2024
Medical Developments International AUD 12.94M 5.87M Dec/2024
Mesoblast USD 12.14M 662K Jun/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Pacific Edge NZD 19.43M 12.04M Sep/2024
Paradigm Biopharmaceuticals AUD 2.36M 639.57K Dec/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024